NCT06889064

A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

A Randomized, Open-label, Single Oral Dose, Three-arm, Parallel Design, Phase 1 Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Boryung Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

The purpose of this clinical study is to evaluate the pharmacokinetic, pharmacodynamic characteristics and the safety after administration by doses of "BR1400-1", "BR1400-2", "BR1400-3" in healthy volunteers

Conditions

• Essential Hypertension

Interventions

Type	Name	Description
DRUG	BR1400-1	One tablet administered alone
DRUG	BR1400-2	One tablet administered alone
DRUG	BR1400-3	One tablet administered alone

Timeline

• Start date: 2024-09-24
• Primary completion: 2024-10-08
• Completion: 2024-10-08
• First posted: 2025-03-21
• Last updated: 2025-03-21

Locations

1 site across 1 country: South Korea